We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Accept
Home » VaxGen Says Trial of Anthrax Vaccine on Clinical Hold
VaxGen Says Trial of Anthrax Vaccine on Clinical Hold
November 6, 2006
In the latest setback in VaxGen’s efforts to fill a government contract to develop a vaccine for anthrax, the company said that the FDA has placed a planned clinical trial of the product on clinical hold.